Please assess the completion status of the following clinical trial:

Trial Title: Influence of Naproxen on Heterotropic Bone Formation Following Hip Arthroscopy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: EARLY_PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* The patient is 18-80 years of age.~* The patient has provided written informed consent.~* The patient is scheduled for hip arthroscopy surgery for treatment of FAI~* The patient has an ASA of I, II, or III.~* The patients understands the explanation of the protocol.~Exclusion Criteria:~* The patient has history of a major GI bleeding event~* The patients has a history of renal impairment or creatinine \> 1.5~* The patient has taken NSAIDs within 48 hours of surgery or in the perioperative period~* The patient has a history of heterotopic ossification following surgery~* The patient has a hypersensitivity reaction to Naproxen~* The patient is undergoing a concomitant procedure in addition to treatment of FAI

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Naproxen (Type: ACTIVE_COMPARATOR): • Group 1: Naproxen 500 mg twice daily for three weeks following surgery beginning postoperative day #1
- Placebo (Type: PLACEBO_COMPARATOR): • Group 2: Placebo twice daily for three weeks following surgery beginning postoperative day #1

Based on this trial design, predict the completion outcome and termination type (if applicable).